Pirmenol

This classification denotes an antiarrhythmic agent with the molecular formula C22H30N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) VZ3B6ACV72, chemically known as 2-pyridinemethanol, alpha-(3-(2,6-dimethyl-1-piperidinyl)propyl)-alpha-phenyl-, cis-(+-)- but more generally known as pirmenol, which bears US NIH Compound Identifier 4853. European Medicines Agency schedules Pirmenol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09925MIG. The term PIRMENOL is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 34, No. 10 1980, List 20). PIRMENOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule pirmenol under HS 29333999 and SITC 51574. As of Q4 2014, PIRMENOL remains US FDA's Preferred Term for this commodity. Pirmenol bears US NLM identifiers UMLS ID C0071144 and NCI Concept Code C81434. SMILES: OC(CCCN1C(CCCC1C)C)(C1CCCCC1)C1NCCCC1.